These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
5/23/2018
7:30 AM ET
Press Release

Repligen to Present at Jefferies 2018 Global Healthcare Conference

5/23/2018

WALTHAM, Mass., May 23, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a global bioprocessing company focused on the development and commercialization of highly innovative technologies...

 Continue Reading
5/17/2018
7:30 AM ET
Press Release

Repligen to Participate in 15th Annual Craig-Hallum Institutional Investor Conference

5/17/2018

WALTHAM, Mass., May 17, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a leading life sciences company focused on bioprocessing technology leadership, today announced that Jon K. Snodg...

 Continue Reading
5/8/2018
7:30 AM ET
Earnings Release

Repligen Reports First Quarter 2018 Financial Results

5/8/2018

Record quarterly revenue of $44.8M represents 46% year-over-year growth Revenue guidance raised to $182-$188 million for full year 2018 WALTHAM, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Repligen Corp...

 Continue Reading
4/30/2018
11:00 AM ET
Press Release

Repligen to Report First Quarter 2018 Financial Results

4/30/2018

WALTHAM, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter of 2018 financial results on Tuesday, May 8, 2018...

 Continue Reading
3/20/2018
7:30 AM ET
Press Release

Repligen Announces Market Launch of OPUS® 80R, Reinforces Technology Leadership in Pre-Packed Chromatography

3/20/2018

- First and only available 80 cm diameter pre-packed column to address large-scale clinical and commercial-scale manufacturing of biological drugs -

WALTHAM, Mass., March 20, 2018 (GLOBE...

 Continue Reading
Displaying 1 to 5 (of 213 releases)